Phase II nonrandomized multicenter study of the impact of radiochemotherapy (65 Gy + cisplatin + 5FU) combined with cetuximab in patients presenting with locally advanced anal cancer
Phase of Trial: Phase II
Latest Information Update: 22 May 2014
At a glance
- Drugs Cetuximab (Primary) ; Cisplatin; Fluorouracil
- Indications Anal cancer
- Focus Therapeutic Use
- Acronyms ACCORD16
- 16 Jan 2012 Planned End Date changed to 7 Oct 2014.
- 07 Apr 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 18 Aug 2009 New trial record